The Structural Disease Center

Filter Your Results

 

News

 

Boston Scientific Makes Investment in Millipede With Acquisition Option

January 24, 2018 -- Boston Scientific Corporation announced that it has closed an investment and entered into an acquisition option agreement with Millipede, Inc., a privately…

FDA Seeks to Strengthen Public Warnings and Recall Notifications; CDRH Outlines Strategic Priorities

January 18, 2018 -- US Food and Drug Administration (FDA) Commissioner Scott Gottlieb, MD, issued a statement on the agency's new policy steps for strengthening public war…

IDE Clinical Trial Begins for BioSense Webster's WaveCrest LAAO Device

January 11, 2018 -- Johnson & Johnson Medical Devices Companies announced that the first patient was enrolled in the WaveCrest investigational device exemption trial of th…

Edwards Acquires Harpoon Medical

December 6, 2017 -- Edwards Lifesciences announced the acquisition of Harpoon Medical, Inc., a privately held medical technology company focused on beating-heart repair for de…

Five-Year Data on LAA Closure Using Watchman Device in Patients With Nonvalvular Atrial Fibrillation Presented, Published

November 2, 2017 -- Five-year results from the PREVAIL trial comparing left atrial appendage (LAA) closure with the Watchman device (Boston Scientific Corporation) to warfarin…

An Interview With Didier Tchétché, MD

September/October 2017—Dr. Tchétché discusses what is on the horizon for valvular disease intervention, new features at his clinic in France, and how he prepares for live case presentations.

United States Arm of ALIVE Study Begins for BioVentrix Revivent TC System

October 4, 2017 -- BioVentrix, Inc. announced enrollment of the first patient in the United States arm of the ALIVE pivotal clinical trial. The trial is designed to demonstrat…

Enrollment Completed in Pivotal Trial of Essential Medical's Manta Large-Bore Vascular Closure Device

October 2, 2017 -- Essential Medical, Inc. announced the completion of enrollment in the United States pivotal trial of its Manta large-bore vascular closure device. The trial…

 

advertisement

 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Cardiac Interventions Today

Cardiac Interventions Today (ISSN 2572-5955 print and ISSN 2572-5963 online) is a publication dedicated to providing comprehensive coverage of the latest developments in technology, techniques, clinical studies, and regulatory and reimbursement issues in the field of coronary and cardiac interventions. Cardiac Interventions Today premiered in March 2007 and each edition contains a variety of topics in a flexible format, including articles covering various perspectives on current clinical topics, in-depth interviews with expert physicians, overviews of available technologies, industry news, and insights into the issues affecting today's interventional cardiology practices.